Medmira Stock Today
| MMIRF Stock | USD 0.06 0.00 0.00% |
Performance10 of 100
| Odds Of DistressOver 66
|
MedMira is trading at 0.0574 as of the 26th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0574. MedMira has more than 66 % chance of experiencing financial distress in the next few years of operation. However, it had a very ok returns during the last 90 days. Equity ratings for MedMira are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America, the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. The company has 697.45 M outstanding shares. More on MedMira
Moving against MedMira Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MedMira Pink Sheet Highlights
| CEO | Hermes Chan |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Biotechnology, Healthcare (View all Sectors) |
MedMira [MMIRF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 77.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedMira's market, we take the total number of its shares issued and multiply it by MedMira's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MedMira classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 697.45 M outstanding shares.
MedMira has accumulated about 396.14 K in cash with (1.88 M) of positive cash flow from operations.
Check MedMira Probability Of Bankruptcy
Ownership AllocationMedMira maintains a total of 697.45 Million outstanding shares. MedMira secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.39 % of MedMira outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MedMira Ownership Details
MedMira Risk Profiles
| Mean Deviation | 9.7 | |||
| Standard Deviation | 38.68 | |||
| Variance | 1495.8 | |||
| Risk Adjusted Performance | 0.1063 |
MedMira Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in MedMira without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Other Information on Investing in MedMira Pink Sheet
MedMira financial ratios help investors to determine whether MedMira Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.